The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy

BACKGROUND: Non-alcoholic Fatty Liver Disease (NAFLD) has a high prevalence among persons with HIV infection. Since Integrase Strand Transfer Inhibitors (INSTIs) are used worldwide and have been associated with weight gain, we must determine their effect in the development of NAFLD and Non-alcoholic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Sara Rodrigues, Leite, Ana Rita, Lino, Rita, Guimarães, André Rodrigues, Pineiro, Carmela, Serrão, Rosário, Freitas, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464196/
https://www.ncbi.nlm.nih.gov/pubmed/37620821
http://dx.doi.org/10.1186/s12879-023-08530-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464196/
https://www.ncbi.nlm.nih.gov/pubmed/37620821
http://dx.doi.org/10.1186/s12879-023-08530-3

Ejemplares similares